Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRalpha) inhibitor. Farletuzumab is a therapeutic humanized monoclonal antibody with high affinity for FRalpha. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRalpha. Farletuzumab can be used in research of cancer.
Purity:
99.0%
CAS Number:
[896723-44-7]
* VAT and and shipping costs not included. Errors and price changes excepted